Fiduciary Trust’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
1,824
-95
-5% -$16.8K ﹤0.01% 813
2026
Q1
$345K Buy
1,919
+106
+6% +$18.1K ﹤0.01% 693
2025
Q4
$256K Buy
+1,813
New +$206K ﹤0.01% 763
2023
Q2
Sell
-1,313
Closed -$290K 626
2023
Q1
$290K Buy
1,313
+310
+31% +$76.4K 0.01% 540
2022
Q4
$218K Hold
1,003
﹤0.01% 590
2022
Q3
$265K Buy
+1,003
New +$255K 0.01% 545
2022
Q2
Sell
-1,795
Closed -$397K 628
2022
Q1
$397K Sell
1,795
-42
-2% -$8.87K 0.01% 512
2021
Q4
$430K Hold
1,837
0.01% 496
2021
Q3
$403K Hold
1,837
0.01% 509
2021
Q2
$310K Hold
1,837
0.01% 551
2021
Q1
$268K Buy
1,837
+300
+20% +$48.1K 0.01% 548
2020
Q4
$226K Buy
+1,537
New +$182K ﹤0.01% 539

Other funds holding ALB

Fiduciary Trust's ALB Position: Q2 2026 in Review

Fiduciary Trust reduced its Albemarle (ALB) stake by 5% in Q2 2026, selling an estimated $16.8K and leaving 1,824 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

Fiduciary Trust first reported a position in ALB in Q4 2020 and has held it in 12 quarters since. The position peaked at $430K in Q4 2021. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Fiduciary Trust held 1,824 shares of Albemarle worth $246K as of Q2 2026.
  • Fiduciary Trust sold 95 Albemarle shares in Q2 2026, an estimated $16.8K.
  • Albemarle made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #813 holding.
  • Fiduciary Trust first reported a position in Albemarle in Q4 2020 and has held it in 12 quarters since.
  • Fiduciary Trust's Albemarle position peaked at $430K in Q4 2021.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.